We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.65B
1-Year Est. Return 18.1%
This Fund
S&P 500
This Quarter Est. Return
-0.22%
1 Year Est. Return
+18.1%
3 Year Est. Return
+53.4%
5 Year Est. Return
+63.18%
10 Year Est. Return
+288.04%
AUM
$777M
AUM Growth
-$10.7M
Cap. Flow
-$2.88M
Cap. Flow %
-0.37%
Top 10 Hldgs %
22.01%
Holding
267
New
2
Increased
69
Reduced
89
Closed
10

Top Buys

Rank Stock Value
1
VZ icon
Verizon
VZ
+$1.46M
2
AGN
Allergan plc
AGN
+$662K
3
DIS icon
Walt Disney
DIS
+$472K
4
WY icon
Weyerhaeuser
WY
+$319K
5
ATW
Atwood Oceanics
ATW
+$311K

Top Sells

Rank Stock Value
1
VIVO
Meridian Bioscience Inc
VIVO
+$2.13M
2
FRX
FOREST LABORATORIES INC
FRX
+$880K
3
ABBV icon
AbbVie
ABBV
+$539K
4
NLSN
Nielsen Holdings plc
NLSN
+$388K
5
GXC icon
State Street SPDR S&P China ETF
GXC
+$361K

Sector Composition

Rank Sector Weight
1 Healthcare 18.02%
2 Miscellaneous 14.73%
3 Industrials 14.1%
4 Technology 12.24%
5 Consumer Staples 10.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GOOG icon
76
Alphabet (Google) Class C
GOOG
$4.15T
$3.22M 0.41%
110,884
+8,664
+8% +$251K
FCX icon
77
Freeport-McMoran
FCX
$99.1B
$3.07M 0.39%
94,012
+1,400
+2% +$50.9K
INTC icon
78
Intel
INTC
$515B
$3.02M 0.39%
86,767
-650
-0.7% -$22K
JPM icon
79
JPMorgan Chase
JPM
$916B
$2.94M 0.38%
48,768
– –
TGT icon
80
Target
TGT
$70.7B
$2.89M 0.37%
46,177
– –
DIS icon
81
Walt Disney
DIS
$185B
$2.86M 0.37%
32,167
+5,355
+20% +$472K
J icon
82
Jacobs Solutions
J
$17B
$2.81M 0.36%
69,472
-108
-0.2% -$4.71K
AXP icon
83
American Express
AXP
$219B
$2.67M 0.34%
30,479
– –
ESV
84
DELISTED
Ensco Rowan plc
ESV
$2.67M 0.34%
16,136
-10
-0.1% -$1.98K
D icon
85
Dominion Energy
D
$56.6B
$2.65M 0.34%
38,420
– –
NVO
86
Novo Nordisk
NVO
$189B
$2.62M 0.34%
109,980
– –
MHFI
87
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
$2.62M 0.34%
31,000
– –
THO icon
88
Thor Industries
THO
$3.75B
$2.61M 0.34%
50,697
-338
-0.7% -$18.1K
APD icon
89
Air Products & Chemicals
APD
$64.3B
$2.59M 0.33%
21,531
-2,649
-11% -$324K
NSC icon
90
Norfolk Southern
NSC
$72.2B
$2.59M 0.33%
23,208
– –
AKAM icon
91
Akamai
AKAM
$15.2B
$2.57M 0.33%
43,021
-325
-0.7% -$19.5K
BMY icon
92
Bristol-Myers Squibb
BMY
$130B
$2.48M 0.32%
48,365
+700
+1% +$35K
WFC icon
93
Wells Fargo
WFC
$269B
$2.35M 0.3%
45,212
+235
+0.5% +$12.1K
GXC icon
94
State Street SPDR S&P China ETF
GXC
$464M
$2.34M 0.3%
30,500
-4,505
-13% -$361K
TMO icon
95
Thermo Fisher Scientific
TMO
$235B
$2.32M 0.3%
19,050
-210
-1% -$25.5K
ROP icon
96
Roper Technologies
ROP
$38.2B
$2.3M 0.3%
15,692
+145
+0.9% +$21.3K
IWC icon
97
iShares Micro-Cap ETF
IWC
$1.42B
$2.25M 0.29%
32,335
+2,940
+10% +$214K
APC
98
DELISTED
Anadarko Petroleum
APC
$2.2M 0.28%
21,649
-50
-0.2% -$5.39K
FDX icon
99
FedEx
FDX
$73.3B
$2.16M 0.28%
13,389
-6
-0% -$911
SHW icon
100
Sherwin-Williams
SHW
$78.6B
$2.12M 0.27%
29,100
-510
-2% -$36.2K
2 3
4
5 6

Similar funds

MCIL
MFF Capital Investments Ltd Sydney $1.65B AUM
BCM
BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return
SOS
Silver Oak Securities Jackson, Tennessee $1.65B AUM 29.37% 1-Year Est. Return
GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
NPA
Nichols & Pratt Advisers Boston, Massachusetts $1.65B AUM 22.9% 1-Year Est. Return
AAM
Aureus Asset Management Boston, Massachusetts $1.65B AUM 26.32% 1-Year Est. Return
OHIF
Oriental Harbor Investment Fund Hong Kong $1.65B AUM 184.75% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.65B AUM 26.74% 1-Year Est. Return

Boston Family Office's Q3 2014 Portfolio in Review

As of Q3 2014, Boston Family Office held 267 positions worth $777M, down 1.4% from $788M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Trading was light in Q3 2014: portfolio turnover was 4.5%. Boston Family Office opened 2 new positions and exited 10, leaving the 267-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Miscellaneous and Industrials.

  • Boston Family Office's largest Q3 2014 buy was Allergan plc: 2,957 shares worth $713K.
  • Boston Family Office added most to Verizon in Q3 2014, an estimated $1.46M increase.
  • Boston Family Office's biggest Q3 2014 reduction was AbbVie, cutting an estimated $539K.
  • Boston Family Office fully exited Meridian Bioscience Inc in Q3 2014, selling an estimated $2.13M.
  • Boston Family Office's ten largest holdings make up 22% of its $777M portfolio in Q3 2014.
  • Boston Family Office opened 2 new positions and closed 10 in Q3 2014.
  • Boston Family Office's portfolio value fell 1.4% quarter-over-quarter to $777M.

Based on Boston Family Office's 13F filing for Q3 2014, filed 31 Oct 2014.